Suchergebnisse - "Lua, Wai-Heng"

PubPharm (23)

1

Essentially leading antibody production: An investigation of amino acids, myeloma and natural V-region signal peptides in producing Pertuzumab and Trastuzumab variants

enthalten in: bioRxiv.org | 2024

von Ling, W. | Su, C. | Lua, W. | +4

2

Molecular insight into Nickel(II) binding by Her2-specific IgE: a possible mechanistic insight into the pathogenesis of Type I nickel hypersensitivity

enthalten in: bioRxiv.org | 2023

von Su, C. | Lua, W. | Poh, J. | +3

3

Engaging the ‘A’ Class Antibody: Variable-Heavy (VH) region influencing IgA1&2 engagement of FcαRI and superantigen proteins G, A, and L

enthalten in: bioRxiv.org | 2023

von Ling, W. | Su, C. | Lua, W. | +5

4

Variable-heavy (VH) families influencing IgA1&2 engagement to the antigen, FcαRI and superantigen proteins G, A, and L

enthalten in: Scientific reports | 2022

von Ling, W. | Su, C. | Lua, W. | +5

5

Molecular Insights of Nickel Binding to Therapeutic Antibodies as a Possible New Antibody Superantigen

enthalten in: Frontiers in immunology | 2021

von Su, C. | Lua, W. | Poh, J. | +3

6

Sagacity in antibody humanization for therapeutics, diagnostics and research purposes : considerations of antibody elements and their roles

enthalten in: Antibody therapeutics | 2020

von Ling, W. | Lua, W. | Gan, S.

7

Essentially Leading Antibody Production : An Investigation of Amino Acids, Myeloma, and Natural V-Region Signal Peptides in Producing Pertuzumab and Trastuzumab Variants

enthalten in: Frontiers in immunology | 2020

von Ling, W. | Su, C. | Lua, W. | +4

8

Allosteric Effects between the Antibody Constant and Variable Regions: A Study of IgA Fc Mutations on Antigen Binding

enthalten in: Preprints.org | 2019

von Su, C. | Lua, W. | Ling, W. | +1

9

Role of the IgE variable heavy chain in FcεRIα and superantigen binding in allergy and immunotherapy

enthalten in: The Journal of allergy and clinical immunology | 2019

von Lua, W. | Su, C. | Yeo, J. | +4

10

Author Correction : The effects of Antibody Engineering CH and CL in Trastuzumab and Pertuzumab recombinant models: Impact on antibody production and antigen-binding

enthalten in: Scientific reports | 2018

von Lua, W. | Ling, W. | Yeo, J. | +3

ErratumFor: Sci Rep. 2018 Jan 15;8(1):718. - PMID 29335579